Here are 10 milestones for spine devices and implants.
Spinal orthopedics company AxioMed completed the final closing of its Series D financing to raise $5 million from current and new investors.
Premier healthcare alliance singed new agreements for spinal implants and related products with Aesculap Implant Systems, Lanx, Stryker Spine, US Arthroplasty and Zimmer.
Salt Lake City-based Crocker Spinal Technologies has been chosen to develop and market a new biomedical artificial disc for treating patients with chronic back pain. The device was developed by Brigham Young University engineering professors and an alumnus, who designed the device to duplicate the natural motion of the spine.
The U.S. Department of Justice announced it would end its four-year investigation related to off-label use of Medtronic's Infuse for spinal fusions. Surgeons are able to use the product off-label but the device company cannot market the product for off-label use.
Paradigm Spine announced two key findings based on its IDE trail for coflex, showing that coflex patients experienced shorter operative times, lower estimated blood loss and shorter length of stays than patients undergoing spinal fusion.
Pioneer Technology's nanOss Bioactive bone graft was successfully implanted into a human. The bone graft uses proprietary nanocrystalline hydroxyapatite and collagen-based biopolymer to promote bone growth in the posterolateral spine.
SI-BONE announced the company has exceeded 100 surgeons in Europe trained in the iFuse implant system for minimally invasive sacroiliac joint surgery. The company expects to train an additional 100 surgeons in Europe over the next 12 months.
A German District Court in Mannheim dismissed Synthes' patent infringement claims against Spinal Kinetics related to the company's M6-C cervical and M6-L lumbar artificial discs for treating patients with degenerative disc disease.
SurgLine singed a three-year agreement to offer its low-cost surgical products to Castlegate Holdings, which will provide the products to rural hospitals, ambulatory surgery centers and physician groups in California.
InterFuse, developed by Vertebral Technologies, has been implanted over 2,000 times worldwide. The company also announced the 100th use of its InterFuse T for transforaminal lumbar interbody fusion in the United States.
Related Articles on Spine Devices:
Precision Spine Acquires Spinal USA, Precision Medical for $72M
20 Spine Devices Receive FDA 510(k) Clearance in May
Korean FDA Approves Mazor Robotics' Renaissance Robotic Platform
Spinal orthopedics company AxioMed completed the final closing of its Series D financing to raise $5 million from current and new investors.
Premier healthcare alliance singed new agreements for spinal implants and related products with Aesculap Implant Systems, Lanx, Stryker Spine, US Arthroplasty and Zimmer.
Salt Lake City-based Crocker Spinal Technologies has been chosen to develop and market a new biomedical artificial disc for treating patients with chronic back pain. The device was developed by Brigham Young University engineering professors and an alumnus, who designed the device to duplicate the natural motion of the spine.
The U.S. Department of Justice announced it would end its four-year investigation related to off-label use of Medtronic's Infuse for spinal fusions. Surgeons are able to use the product off-label but the device company cannot market the product for off-label use.
Paradigm Spine announced two key findings based on its IDE trail for coflex, showing that coflex patients experienced shorter operative times, lower estimated blood loss and shorter length of stays than patients undergoing spinal fusion.
Pioneer Technology's nanOss Bioactive bone graft was successfully implanted into a human. The bone graft uses proprietary nanocrystalline hydroxyapatite and collagen-based biopolymer to promote bone growth in the posterolateral spine.
SI-BONE announced the company has exceeded 100 surgeons in Europe trained in the iFuse implant system for minimally invasive sacroiliac joint surgery. The company expects to train an additional 100 surgeons in Europe over the next 12 months.
A German District Court in Mannheim dismissed Synthes' patent infringement claims against Spinal Kinetics related to the company's M6-C cervical and M6-L lumbar artificial discs for treating patients with degenerative disc disease.
SurgLine singed a three-year agreement to offer its low-cost surgical products to Castlegate Holdings, which will provide the products to rural hospitals, ambulatory surgery centers and physician groups in California.
InterFuse, developed by Vertebral Technologies, has been implanted over 2,000 times worldwide. The company also announced the 100th use of its InterFuse T for transforaminal lumbar interbody fusion in the United States.
Related Articles on Spine Devices:
Precision Spine Acquires Spinal USA, Precision Medical for $72M
20 Spine Devices Receive FDA 510(k) Clearance in May
Korean FDA Approves Mazor Robotics' Renaissance Robotic Platform